Literature DB >> 28084215

Dialysis Arteriovenous Fistula Failure and Angioplasty: Intimal Hyperplasia and Other Causes of Access Failure.

Juan C Duque1, Marwan Tabbara2, Laisel Martinez2, Jose Cardona3, Roberto I Vazquez-Padron2, Loay H Salman4.   

Abstract

The arteriovenous fistula (AVF) is the preferred hemodialysis access type because it has better patency rates and fewer complications than other access types. However, primary failure remains a common problem impeding AVF maturation and adding to patients' morbidity and mortality. Juxta-anastomotic (or inflow) stenosis is the most common reason leading to primary failure, and percutaneous transluminal angioplasty continues to be the gold-standard treatment with excellent success rates. Intimal hyperplasia (IH) has been traditionally blamed as the main pathophysiologic culprit, but new evidence raises doubts regarding the contribution of IH alone to primary failure. We report a 64-year-old man with a 2-stage brachiobasilic AVF that was complicated by failure 4 months after creation. An angiogram showed multiple juxta-anastomotic and midfistula stenotic lesions. Percutaneous transluminal angioplasty was successful in assisting maturation and subsequently cannulating the AVF for hemodialysis treatment. We failed to identify the underlying cause of stenosis because biopsy specimens from fistula tissue obtained at the time of transposition revealed no occlusive IH. This case emphasizes the need for additional research on factors contributing to AVF failure besides IH and highlights the need for more therapeutic options to reduce AVF failure rate.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arteriovenous fistula (AVF); angioplasty; hemodialysis; intimal hyperplasia; primary failure; stenosis; vascular access dysfunction; vascular remodeling

Mesh:

Year:  2016        PMID: 28084215      PMCID: PMC5240806          DOI: 10.1053/j.ajkd.2016.08.025

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  32 in total

1.  Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I).

Authors:  Charmaine E Lok; Michael Allon; Louise Moist; Matthew J Oliver; Hemal Shah; Deborah Zimmerman
Journal:  J Am Soc Nephrol       Date:  2006-09-20       Impact factor: 10.121

2.  Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model.

Authors:  Burnett Kelly; Murad Melhem; Jianhua Zhang; Gerald Kasting; Jinsong Li; Mahesh Krishnamoorthy; Sue Heffelfinger; Steven Rudich; Pankaj Desai; Prabir Roy-Chaudhury
Journal:  Nephrol Dial Transplant       Date:  2006-07-05       Impact factor: 5.992

Review 3.  Strategies for planning the optimal dialysis access for an individual patient.

Authors:  David A Drew; Charmaine E Lok
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

Review 4.  Infectious complications of the hemodialysis access.

Authors:  G M Nassar; J C Ayus
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

5.  Superiority of autogenous arteriovenous hemodialysis access: maintenance of function with fewer secondary interventions.

Authors:  Ganesha B Perera; Mark P Mueller; Stephen M Kubaska; Samuel E Wilson; Peter F Lawrence; Roy M Fujitani
Journal:  Ann Vasc Surg       Date:  2004-01-20       Impact factor: 1.466

6.  Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts.

Authors:  Karen Woo; Gheorghe Doros; Tina Ng; Alik Farber
Journal:  J Vasc Surg       Date:  2009-09-26       Impact factor: 4.268

7.  Aggressive treatment of early fistula failure.

Authors:  Gerald A Beathard; Perry Arnold; Jerry Jackson; Terry Litchfield
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

8.  Hospital specific aspects predominantly determine primary failure of hemodialysis arteriovenous fistulas.

Authors:  Henricus J T A M Huijbregts; Michiel L Bots; Frans L Moll; Peter J Blankestijn
Journal:  J Vasc Surg       Date:  2007-05       Impact factor: 4.268

Review 9.  The Role of Endovascular Stents in Dialysis Access Maintenance.

Authors:  Mohamad El Kassem; Issam Alghamdi; Roberto I Vazquez-Padron; Arif Asif; Oliver Lenz; Tina Sanjar; Fadi Fayad; Loay Salman
Journal:  Adv Chronic Kidney Dis       Date:  2015-11       Impact factor: 3.620

10.  Intimal changes in the cephalic vein of renal failure patients before arterio-venous fistula (AVF) construction.

Authors:  Mahmoud A Wali; Refaat A Eid; Madhu Dewan; Mohammad A Al-Homrany
Journal:  J Smooth Muscle Res       Date:  2003-08
View more
  11 in total

Review 1.  Medical safety in the care of the person with end-stage kidney disease.

Authors:  John V Duronville; Clarissa J Diamantidis
Journal:  Semin Dial       Date:  2018-01-07       Impact factor: 3.455

2.  Nitric oxide releasing nanomatrix gel treatment inhibits venous intimal hyperplasia and improves vascular remodeling in a rodent arteriovenous fistula.

Authors:  Maheshika Somarathna; Patrick Tj Hwang; Reid C Millican; Grant C Alexander; Tatyana Isayeva-Waldrop; Jennifer A Sherwood; Brigitta C Brott; Isabelle Falzon; Hannah Northrup; Yan-Ting Shiu; Chris J Stubben; John Totenhagen; Ho-Wook Jun; Timmy Lee
Journal:  Biomaterials       Date:  2021-11-18       Impact factor: 15.304

3.  Less primary fistula failure in hypertensive patients.

Authors:  Mohammad Rezapour; Morteza Khavanin Zadeh; Mohammad Mehdi Sepehri; Mahmood Alborzi
Journal:  J Hum Hypertens       Date:  2018-03-27       Impact factor: 3.012

4.  Similar degree of intimal hyperplasia in surgically detected stenotic and nonstenotic arteriovenous fistula segments: a preliminary report.

Authors:  Juan C Duque; Marwan Tabbara; Laisel Martinez; Angela Paez; Guillermo Selman; Loay H Salman; Omaida C Velazquez; Roberto I Vazquez-Padron
Journal:  Surgery       Date:  2017-12-11       Impact factor: 3.982

5.  Angioplasty Induced Changes in Dialysis Vascular Access Compliance.

Authors:  Yihao Zheng; Brian J Thelen; Nirmala Rajaram; Venkataramu N Krishnamurthy; James Hamilton; Miguel Angel Funes-Lora; Timothy Morgan; Lenar Yessayan; Brandie Bishop; Nickolas Osborne; Peter Henke; Albert J Shih; William F Weitzel
Journal:  Ann Biomed Eng       Date:  2021-08-11       Impact factor: 3.934

6.  1α,25-Dihydroxyvitamin D3 Encapsulated in Nanoparticles Prevents Venous Neointimal Hyperplasia and Stenosis in Porcine Arteriovenous Fistulas.

Authors:  Avishek K Singh; Chuanqi Cai; Sreenivasulu Kilari; Chenglei Zhao; Michael L Simeon; Edwin Takahashi; Elazer R Edelman; Hyunjoon Joon Kong; Thanila Macedo; Ravinder J Singh; Matthew W Urban; Rajiv Kumar; Sanjay Misra
Journal:  J Am Soc Nephrol       Date:  2021-02-24       Impact factor: 10.121

7.  Use of Paclitaxel Eluting Stents in Arteriovenous Fistulas: A Pilot Study.

Authors:  Krystal Dinh; Shannon D Thomas; Tae Cho; John Swinnen; Phillip Crowe; Ramon L Varcoe
Journal:  Vasc Specialist Int       Date:  2019-12-31

8.  Predictors associated with early and late restenosis of arteriovenous fistulas and grafts after percutaneous transluminal angiography.

Authors:  Quan Zheng; Bingying Xie; Xinfu Xie; Wenhao Zhang; Jihua Hou; Zhonglin Feng; Yiming Tao; Feng Yu; Li Zhang; Zhiming Ye
Journal:  Ann Transl Med       Date:  2021-01

9.  Uncommon Surgical Management by AVF between the Great Saphenous Vein and Anterior Tibial Artery for Old Radiocephalic AVF Failure.

Authors:  Réka Kaller; Adrian Vasile Mureșan; Emil Marian Arbănași; Eliza Mihaela Arbănași; István Kovács; Emőke Horváth; Bogdan Andrei Suciu; Ioan Hosu; Eliza Russu
Journal:  Life (Basel)       Date:  2022-04-03

10.  Morphological Lesion Types Are Associated with Primary and Secondary Patency Rates after High-Pressure Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas.

Authors:  Li Chen; Weichen Zhang; Jinyun Tan; Min Hu; Weihao Shi; Minmin Zhang; Yong Wang; Bo Yu; Jing Chen
Journal:  Blood Purif       Date:  2021-07-28       Impact factor: 3.348

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.